Great West Life Assurance CO Solid Biosciences Inc. Transaction History

Great West Life Assurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 17, 2020	SELL	$2.1 - $3.42 $3,591 - $5,848	-1,710 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$2.82 - $12.9 $4,822 - $22,059	1,710 New	1,710 $7,000
Q3 2019 Oct 25, 2019	SELL	$4.33 - $11.64 $13,955 - $37,515	-3,223 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$21.32 - $46.34 $68,714 - $149,353	3,223 New	3,223 $83,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $24.9M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

Stay updated on Great West Life Assurance CO with notifications on news.